DANISH BIO – DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately four "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

News

Servier signs a definitive agreement to acquire Symphogen to boost its antibody capabilities and leverage its R&D pipeline 03 April 2020

Servier, an independent international pharmaceutical company, announced today that it has entered into... Read more

Y-mAbs Announces Submission of Naxitamab Biologics License Application to U.S. FDA 01 April 2020

On April 01, 2020, Y-mAbs announced that the Company has completed the submission of its Biologics License... Read more

Nyheder

NORGINE B.V. ACQUIRES AZANTA A/S 24 March 2020

NORGINE B.V. ACQUIRES AZANTA A/S STRENGTHENING ITS POSITION AS A LEADING EUROPEAN SPECIALIST PHARMACEUTICAL... Read more

Corona postpones all events in DANISH BIO – DANSK BIOTEK 19 March 2020

During the corona crisis, DANISH BIO – DANSK BIOTEK is of course following the advice provided by the... Read more

Nyheder

The Life and Death of Startup Accelerators 03 March 2020

In 2019, Accelerace celebrated its 10th anniversary. However, Accelerace was never supposed to become... Read more

Y-mAbs’ GD2-GD3 Vaccine Granted Rare Pediatric Disease Designation 13 December 2019

NEW YORK, Dec. 12, 2019 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)... Read more

MC2 Therapeutics Announces FDA Acceptance of its New Drug Application for Wynzora™ Cream for Treatment of Plaque Psoriasis 22 November 2019

COPENHAGEN, Denmark, November 21, 2019 / B3C newswire / — MC2 Therapeutics, an emerging pharmaceutical... Read more

Y-mAbs Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares 04 November 2019

NEW YORK, Nov. 01, 2019 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)... Read more

Y-mAbs Announces Proposed Public Offering of Common Stock 31 October 2019

NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)... Read more

Copyright 2019 DANISH BIO – DANSK BIOTEK. All rights reserved.

created by: Mastafu Design